Biologics Manufacturing Korea 2025 / Cell & Gene Therapy East Asia 2025
14 Years of Excellence: South Korea’s Biggest Biologics Manufacturing ConferenceBiologics Manufacturing Korea 2025 unites global leaders to showcase breakthroughs in AI, automation, biosimilars, and supply chain excellence. Join us to shape the future of biotech in Asia’s powerhouse market.As we look to the future, the 14th Biologics Manufacturing Korea 2025 aims to serve as the premier platform for collaboration, knowledge exchange, and strategic partnerships. This year's conference will delve into critical topics, including advanced strategies in upstream processing, the future of biomanufacturing through automation and AI technologies, insights on regulatory pathways for biosimilars and innovative approaches to downstream processing and supply chain optimization.Biologics Manufacturing Korea 2025 will be co-located with the CGT East Asia 2025 and ADC & Bioconjugate East Asia 2025 events, enhancing the opportunity for interdisciplinary discussions and collaboration.
#biomanufacturing #CDMO #cellandgene #pharma